EUDA Health Holdings Ltd.

As of May 10, 2023, EUDA Health Holdings Ltd. is considered risky and overvalued, with significant negative financial ratios and a year-to-date return of -20%, contrasting sharply with the S&P 500's gain of 2.44%.

As of May 15, 2025, the market trend is mildly bearish, indicated by bearish signals from the weekly MACD and Bollinger Bands, despite mixed monthly indicators, with the stock down 4.79% in the last month and 20% year-to-date.

EUDA Health Holdings Ltd. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $1 million and a net loss of $6 million as of June 2023, with a market cap of $133.95 million. Key metrics include a negative P/E ratio and a return on equity of 95.35%.

As of Jun 18, EUDA Health Holdings Ltd. has a market capitalization of 133.95 million, classifying it as a Micro Cap company. As of Jun 23, the company reported net sales of 2.81 million and a consolidated net profit of -9.33 million.